 Martin Boublik
Concepts (303)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Football | 8 | 2022 | 77 | 2.670 |
Why?
| | Tendon Injuries | 5 | 2018 | 76 | 1.420 |
Why?
| | Ribosomes | 29 | 1994 | 148 | 1.280 |
Why?
| | Soccer | 1 | 2022 | 34 | 0.830 |
Why?
| | Return to Sport | 1 | 2022 | 78 | 0.820 |
Why?
| | Escherichia coli | 32 | 1994 | 730 | 0.670 |
Why?
| | Pectoralis Muscles | 1 | 2018 | 14 | 0.650 |
Why?
| | RNA, Ribosomal | 15 | 1994 | 157 | 0.610 |
Why?
| | Ribosomal Proteins | 16 | 1994 | 70 | 0.600 |
Why?
| | Knee Injuries | 4 | 2011 | 89 | 0.520 |
Why?
| | Brain Concussion | 1 | 2022 | 467 | 0.520 |
Why?
| | Athletic Injuries | 4 | 2022 | 455 | 0.520 |
Why?
| | Anterior Cruciate Ligament Injuries | 3 | 2011 | 131 | 0.410 |
Why?
| | Patellar Ligament | 2 | 2011 | 22 | 0.410 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2010 | 11 | 0.370 |
Why?
| | Arthritis, Infectious | 1 | 2010 | 50 | 0.350 |
Why?
| | Groin | 1 | 2009 | 13 | 0.330 |
Why?
| | Orthopedic Procedures | 1 | 2011 | 213 | 0.320 |
Why?
| | Microscopy, Electron | 26 | 1993 | 406 | 0.270 |
Why?
| | RNA, Ribosomal, 16S | 4 | 1991 | 492 | 0.230 |
Why?
| | Nucleic Acid Conformation | 17 | 1994 | 664 | 0.220 |
Why?
| | Postoperative Complications | 2 | 2010 | 2167 | 0.200 |
Why?
| | Anterior Cruciate Ligament | 2 | 2011 | 79 | 0.180 |
Why?
| | RNA, Transfer | 6 | 1991 | 119 | 0.180 |
Why?
| | Athletes | 1 | 2022 | 323 | 0.170 |
Why?
| | Recovery of Function | 2 | 2013 | 578 | 0.160 |
Why?
| | Circular Dichroism | 17 | 1990 | 135 | 0.150 |
Why?
| | Microscopy, Electron, Scanning | 7 | 1994 | 194 | 0.140 |
Why?
| | Artemia | 4 | 1992 | 8 | 0.140 |
Why?
| | RNA, Transfer, Amino Acyl | 3 | 1993 | 8 | 0.140 |
Why?
| | Treatment Outcome | 5 | 2013 | 9165 | 0.120 |
Why?
| | Rupture | 2 | 2013 | 95 | 0.120 |
Why?
| | Thigh | 2 | 2013 | 53 | 0.120 |
Why?
| | Macromolecular Substances | 8 | 1993 | 200 | 0.120 |
Why?
| | Transplantation, Autologous | 2 | 2011 | 176 | 0.110 |
Why?
| | Humans | 19 | 2022 | 115902 | 0.110 |
Why?
| | Return to Work | 1 | 2013 | 20 | 0.110 |
Why?
| | Peptide Elongation Factor Tu | 1 | 1993 | 5 | 0.110 |
Why?
| | Molecular Weight | 5 | 1993 | 335 | 0.110 |
Why?
| | Shoulder Injuries | 1 | 1993 | 53 | 0.110 |
Why?
| | Knee Prosthesis | 1 | 1993 | 15 | 0.110 |
Why?
| | Microscopy, Electron, Scanning Transmission | 1 | 1992 | 2 | 0.110 |
Why?
| | Transplantation, Homologous | 2 | 2011 | 397 | 0.110 |
Why?
| | Arthritis, Juvenile | 1 | 1993 | 42 | 0.110 |
Why?
| | Adult | 7 | 2018 | 30817 | 0.100 |
Why?
| | Rotator Cuff | 1 | 2012 | 44 | 0.100 |
Why?
| | Quadriceps Muscle | 1 | 2013 | 101 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 3 | 2011 | 3087 | 0.100 |
Why?
| | Retrospective Studies | 4 | 2013 | 12616 | 0.100 |
Why?
| | Nucleotides | 2 | 1991 | 113 | 0.100 |
Why?
| | Protein Biosynthesis | 5 | 1991 | 389 | 0.100 |
Why?
| | Suture Techniques | 1 | 2012 | 130 | 0.100 |
Why?
| | RNA, Fungal | 1 | 1991 | 66 | 0.100 |
Why?
| | Protein Conformation | 12 | 1994 | 822 | 0.090 |
Why?
| | RNA, Ribosomal, 18S | 1 | 1990 | 22 | 0.090 |
Why?
| | Arthroscopy | 1 | 2012 | 200 | 0.090 |
Why?
| | Tendons | 1 | 2011 | 120 | 0.090 |
Why?
| | Poliovirus | 3 | 1990 | 77 | 0.090 |
Why?
| | Peptides | 3 | 1994 | 862 | 0.090 |
Why?
| | RNA, Ribosomal, 23S | 1 | 1990 | 12 | 0.090 |
Why?
| | Medial Collateral Ligament, Knee | 1 | 2009 | 6 | 0.090 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 1 | 2011 | 116 | 0.090 |
Why?
| | Male | 14 | 2018 | 56127 | 0.090 |
Why?
| | Interferon Type I | 1 | 1990 | 129 | 0.080 |
Why?
| | Health Care Costs | 1 | 2011 | 386 | 0.080 |
Why?
| | Saccharomyces cerevisiae | 1 | 1991 | 482 | 0.070 |
Why?
| | Young Adult | 3 | 2013 | 10517 | 0.070 |
Why?
| | RNA, Bacterial | 3 | 1988 | 174 | 0.070 |
Why?
| | Osmolar Concentration | 4 | 1991 | 178 | 0.070 |
Why?
| | Buffers | 3 | 1990 | 54 | 0.070 |
Why?
| | Knee Joint | 2 | 2002 | 325 | 0.060 |
Why?
| | Peptide Initiation Factors | 1 | 1983 | 17 | 0.060 |
Why?
| | Heel | 1 | 2002 | 9 | 0.050 |
Why?
| | Contracture | 1 | 2002 | 23 | 0.050 |
Why?
| | HeLa Cells | 4 | 1990 | 568 | 0.050 |
Why?
| | Quality-Adjusted Life Years | 2 | 2012 | 103 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2010 | 1459 | 0.050 |
Why?
| | Probability | 2 | 2012 | 297 | 0.050 |
Why?
| | Female | 7 | 2022 | 60081 | 0.050 |
Why?
| | Anticodon | 3 | 1988 | 22 | 0.050 |
Why?
| | Range of Motion, Articular | 2 | 1993 | 353 | 0.050 |
Why?
| | Affinity Labels | 1 | 1980 | 25 | 0.040 |
Why?
| | Dictyostelium | 1 | 1980 | 11 | 0.040 |
Why?
| | Halobacterium | 1 | 1979 | 3 | 0.040 |
Why?
| | Geobacillus stearothermophilus | 1 | 1979 | 12 | 0.040 |
Why?
| | Nucleic Acid Denaturation | 3 | 1990 | 31 | 0.040 |
Why?
| | Risk Factors | 1 | 2013 | 8714 | 0.040 |
Why?
| | Morphogenesis | 2 | 1991 | 161 | 0.040 |
Why?
| | Ribonucleoproteins | 3 | 1991 | 87 | 0.040 |
Why?
| | Cost-Benefit Analysis | 2 | 2012 | 545 | 0.040 |
Why?
| | Protein Binding | 5 | 1991 | 1919 | 0.040 |
Why?
| | Viral Proteins | 2 | 1981 | 283 | 0.040 |
Why?
| | Leg Injuries | 2 | 2013 | 20 | 0.040 |
Why?
| | Temperature | 4 | 1989 | 590 | 0.040 |
Why?
| | Liver | 2 | 1983 | 1693 | 0.040 |
Why?
| | Surveys and Questionnaires | 1 | 2009 | 4671 | 0.040 |
Why?
| | Cell Cycle | 1 | 1980 | 546 | 0.040 |
Why?
| | RNA, Viral | 2 | 1980 | 561 | 0.040 |
Why?
| | Polyribonucleotides | 1 | 1976 | 1 | 0.030 |
Why?
| | Binding Sites | 7 | 1988 | 1183 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 2 | 1992 | 694 | 0.030 |
Why?
| | Eukaryotic Cells | 2 | 1988 | 33 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 1990 | 2793 | 0.030 |
Why?
| | Cyclic GMP | 1 | 1975 | 80 | 0.030 |
Why?
| | Fluorenes | 1 | 1975 | 38 | 0.030 |
Why?
| | Structure-Activity Relationship | 3 | 1990 | 510 | 0.030 |
Why?
| | Computers | 2 | 1986 | 61 | 0.030 |
Why?
| | Models, Structural | 4 | 1988 | 37 | 0.030 |
Why?
| | Protein Denaturation | 2 | 1990 | 72 | 0.030 |
Why?
| | Guanosine Triphosphate | 2 | 1993 | 85 | 0.030 |
Why?
| | Bacterial Proteins | 3 | 1991 | 738 | 0.030 |
Why?
| | Palpation | 1 | 1993 | 13 | 0.030 |
Why?
| | Histones | 3 | 1975 | 539 | 0.030 |
Why?
| | RNA | 2 | 1976 | 821 | 0.030 |
Why?
| | Thermus thermophilus | 1 | 1993 | 9 | 0.030 |
Why?
| | Tobacco Mosaic Virus | 1 | 1992 | 2 | 0.030 |
Why?
| | Shoulder | 1 | 1993 | 86 | 0.030 |
Why?
| | Statistics as Topic | 2 | 1984 | 299 | 0.030 |
Why?
| | Peripheral Vascular Diseases | 1 | 1993 | 98 | 0.030 |
Why?
| | Fractures, Spontaneous | 1 | 1992 | 14 | 0.030 |
Why?
| | Physical Examination | 1 | 1993 | 224 | 0.030 |
Why?
| | Organogold Compounds | 1 | 1991 | 5 | 0.020 |
Why?
| | Decision Trees | 1 | 2011 | 82 | 0.020 |
Why?
| | Peptide Biosynthesis | 1 | 1991 | 13 | 0.020 |
Why?
| | X-Ray Diffraction | 1 | 1991 | 84 | 0.020 |
Why?
| | Methyltransferases | 1 | 1991 | 61 | 0.020 |
Why?
| | Base Sequence | 3 | 1990 | 2120 | 0.020 |
Why?
| | Shoulder Joint | 1 | 1993 | 160 | 0.020 |
Why?
| | DNA Helicases | 3 | 1981 | 133 | 0.020 |
Why?
| | Movement | 1 | 1993 | 246 | 0.020 |
Why?
| | Prosthesis Design | 1 | 1993 | 290 | 0.020 |
Why?
| | Electron Probe Microanalysis | 1 | 1990 | 3 | 0.020 |
Why?
| | Joint Instability | 1 | 1993 | 166 | 0.020 |
Why?
| | Hydroxyapatites | 1 | 1990 | 13 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1990 | 150 | 0.020 |
Why?
| | Gold | 1 | 1991 | 105 | 0.020 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1990 | 137 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 1991 | 102 | 0.020 |
Why?
| | Muscle Contraction | 1 | 1993 | 398 | 0.020 |
Why?
| | Phosphorus | 1 | 1990 | 81 | 0.020 |
Why?
| | Radiography | 1 | 1993 | 827 | 0.020 |
Why?
| | Reoperation | 1 | 2012 | 526 | 0.020 |
Why?
| | Staining and Labeling | 2 | 1982 | 139 | 0.020 |
Why?
| | Antibody-Dependent Cell Cytotoxicity | 1 | 1989 | 19 | 0.020 |
Why?
| | Bone Neoplasms | 1 | 1992 | 195 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 313 | 0.020 |
Why?
| | Computer Simulation | 1 | 1994 | 887 | 0.020 |
Why?
| | Animals | 13 | 1992 | 32122 | 0.020 |
Why?
| | Antigens, Surface | 1 | 1989 | 151 | 0.020 |
Why?
| | RNA, Transfer, Amino Acid-Specific | 1 | 1988 | 4 | 0.020 |
Why?
| | RNA, Transfer, Val | 1 | 1988 | 3 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2012 | 352 | 0.020 |
Why?
| | Polynucleotides | 2 | 1980 | 13 | 0.020 |
Why?
| | Hydrogen Bonding | 1 | 1988 | 144 | 0.020 |
Why?
| | Prokaryotic Cells | 1 | 1988 | 5 | 0.020 |
Why?
| | Genes, Bacterial | 2 | 1987 | 156 | 0.020 |
Why?
| | Spectrophotometry, Ultraviolet | 3 | 1980 | 75 | 0.020 |
Why?
| | Models, Biological | 3 | 1984 | 1647 | 0.020 |
Why?
| | Thermodynamics | 1 | 1990 | 382 | 0.020 |
Why?
| | Proteins | 1 | 1973 | 922 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 1990 | 1243 | 0.020 |
Why?
| | Water | 1 | 1990 | 418 | 0.020 |
Why?
| | Capsid | 2 | 1977 | 76 | 0.020 |
Why?
| | Drug Stability | 2 | 1979 | 152 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1990 | 2000 | 0.020 |
Why?
| | Molecular Conformation | 3 | 1978 | 138 | 0.020 |
Why?
| | Cell Nucleus | 2 | 1981 | 554 | 0.020 |
Why?
| | Cricetinae | 1 | 1985 | 260 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 1992 | 2814 | 0.020 |
Why?
| | Calcium | 1 | 1990 | 1102 | 0.020 |
Why?
| | Species Specificity | 2 | 1989 | 555 | 0.010 |
Why?
| | DNA | 1 | 1971 | 1358 | 0.010 |
Why?
| | Eukaryotic Initiation Factor-3 | 1 | 1983 | 3 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 1993 | 4446 | 0.010 |
Why?
| | Azides | 2 | 1984 | 46 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 1989 | 1262 | 0.010 |
Why?
| | Monosaccharide Transport Proteins | 1 | 1983 | 45 | 0.010 |
Why?
| | Symporters | 1 | 1983 | 52 | 0.010 |
Why?
| | Kinetics | 3 | 1991 | 1560 | 0.010 |
Why?
| | Pattern Recognition, Automated | 1 | 1982 | 70 | 0.010 |
Why?
| | Membrane Transport Proteins | 1 | 1983 | 137 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 1989 | 1754 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1983 | 1044 | 0.010 |
Why?
| | Nucleoproteins | 1 | 1981 | 24 | 0.010 |
Why?
| | Escherichia coli Proteins | 1 | 1983 | 165 | 0.010 |
Why?
| | Benzopyrenes | 2 | 1978 | 4 | 0.010 |
Why?
| | Adolescent | 2 | 2002 | 17956 | 0.010 |
Why?
| | Middle Aged | 3 | 2012 | 27083 | 0.010 |
Why?
| | Cell Line | 1 | 1985 | 2655 | 0.010 |
Why?
| | Immunoglobulin G | 2 | 1989 | 782 | 0.010 |
Why?
| | Photolysis | 1 | 1980 | 80 | 0.010 |
Why?
| | Photochemistry | 1 | 1980 | 125 | 0.010 |
Why?
| | DNA, Single-Stranded | 1 | 1980 | 112 | 0.010 |
Why?
| | Cross-Linking Reagents | 1 | 1980 | 182 | 0.010 |
Why?
| | Arm Injuries | 1 | 1999 | 23 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 1985 | 1318 | 0.010 |
Why?
| | Antibodies | 2 | 1984 | 374 | 0.010 |
Why?
| | Phenylalanine | 1 | 1979 | 58 | 0.010 |
Why?
| | Bacteria | 1 | 1985 | 731 | 0.010 |
Why?
| | Kidney | 1 | 1985 | 1208 | 0.010 |
Why?
| | Ethers, Cyclic | 1 | 1978 | 7 | 0.010 |
Why?
| | DNA, Viral | 1 | 1980 | 351 | 0.010 |
Why?
| | Oligoribonucleotides | 1 | 1978 | 52 | 0.010 |
Why?
| | Epoxy Compounds | 1 | 1978 | 31 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2002 | 1817 | 0.010 |
Why?
| | Oligonucleotides | 1 | 1978 | 138 | 0.010 |
Why?
| | Antigen-Antibody Reactions | 1 | 1976 | 49 | 0.010 |
Why?
| | United States | 1 | 2013 | 12340 | 0.010 |
Why?
| | Solvents | 2 | 1978 | 109 | 0.010 |
Why?
| | Methods | 2 | 1973 | 59 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 1975 | 484 | 0.010 |
Why?
| | Polyribosomes | 1 | 1975 | 23 | 0.010 |
Why?
| | Spectrum Analysis | 2 | 1973 | 82 | 0.010 |
Why?
| | Cattle | 3 | 1975 | 935 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 1985 | 2362 | 0.010 |
Why?
| | Isomerism | 1 | 1975 | 42 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 2 | 1975 | 513 | 0.010 |
Why?
| | Chromatography, Ion Exchange | 1 | 1975 | 49 | 0.010 |
Why?
| | Acetamides | 1 | 1975 | 25 | 0.010 |
Why?
| | Phenobarbital | 1 | 1974 | 17 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 1981 | 1319 | 0.010 |
Why?
| | Mice | 3 | 1989 | 15073 | 0.010 |
Why?
| | Serotonin | 1 | 1975 | 296 | 0.010 |
Why?
| | Guanidines | 1 | 1973 | 33 | 0.010 |
Why?
| | Urea | 1 | 1973 | 69 | 0.010 |
Why?
| | Pharmaceutical Preparations | 1 | 1974 | 169 | 0.010 |
Why?
| | 5-Methylcytosine | 1 | 1991 | 16 | 0.010 |
Why?
| | Rehabilitation Centers | 1 | 1992 | 32 | 0.010 |
Why?
| | Cytosine | 1 | 1991 | 44 | 0.010 |
Why?
| | Guanine | 1 | 1991 | 76 | 0.010 |
Why?
| | Chromatin | 1 | 1975 | 427 | 0.010 |
Why?
| | Methylation | 1 | 1991 | 206 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1991 | 356 | 0.010 |
Why?
| | Prospective Studies | 1 | 2002 | 6267 | 0.010 |
Why?
| | Models, Molecular | 2 | 1991 | 1391 | 0.010 |
Why?
| | Durapatite | 1 | 1990 | 32 | 0.010 |
Why?
| | Reference Standards | 1 | 1990 | 161 | 0.010 |
Why?
| | Thymectomy | 1 | 1989 | 15 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 1989 | 399 | 0.010 |
Why?
| | Immunoglobulin M | 1 | 1989 | 251 | 0.000 |
Why?
| | T-Phages | 1 | 1987 | 22 | 0.000 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 1987 | 52 | 0.000 |
Why?
| | Ligands | 1 | 1988 | 568 | 0.000 |
Why?
| | Plasmids | 1 | 1987 | 346 | 0.000 |
Why?
| | Flow Cytometry | 1 | 1989 | 1058 | 0.000 |
Why?
| | DNA, Recombinant | 1 | 1985 | 42 | 0.000 |
Why?
| | Cell-Free System | 1 | 1985 | 47 | 0.000 |
Why?
| | Genes | 1 | 1985 | 223 | 0.000 |
Why?
| | Antigen-Antibody Complex | 1 | 1984 | 88 | 0.000 |
Why?
| | Sodium Chloride | 2 | 1975 | 137 | 0.000 |
Why?
| | Genetic Engineering | 1 | 1985 | 81 | 0.000 |
Why?
| | Thymus Gland | 2 | 1975 | 297 | 0.000 |
Why?
| | Cloning, Molecular | 1 | 1985 | 522 | 0.000 |
Why?
| | gamma-Aminobutyric Acid | 1 | 1984 | 152 | 0.000 |
Why?
| | Epitopes | 1 | 1984 | 438 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1992 | 6438 | 0.000 |
Why?
| | Promoter Regions, Genetic | 1 | 1985 | 1129 | 0.000 |
Why?
| | Dinitrophenols | 1 | 1979 | 7 | 0.000 |
Why?
| | Nucleic Acids | 1 | 1979 | 57 | 0.000 |
Why?
| | Valine | 1 | 1979 | 74 | 0.000 |
Why?
| | Immunoassay | 1 | 1979 | 97 | 0.000 |
Why?
| | Chemistry | 1 | 1978 | 39 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1978 | 82 | 0.000 |
Why?
| | Centrifugation, Density Gradient | 1 | 1976 | 41 | 0.000 |
Why?
| | Mutation | 1 | 1987 | 3370 | 0.000 |
Why?
| | Carcinoma, Ehrlich Tumor | 1 | 1975 | 1 | 0.000 |
Why?
| | Puromycin | 1 | 1975 | 11 | 0.000 |
Why?
| | Aminoacylation | 1 | 1975 | 12 | 0.000 |
Why?
| | Cycloheximide | 1 | 1975 | 56 | 0.000 |
Why?
| | Reserpine | 1 | 1975 | 5 | 0.000 |
Why?
| | Sea Urchins | 1 | 1975 | 7 | 0.000 |
Why?
| | Spectrophotometry, Infrared | 1 | 1975 | 45 | 0.000 |
Why?
| | Adenylyl Cyclases | 1 | 1975 | 84 | 0.000 |
Why?
| | Binding, Competitive | 1 | 1975 | 200 | 0.000 |
Why?
| | Dealkylation | 1 | 1974 | 2 | 0.000 |
Why?
| | Cytochrome Reductases | 1 | 1974 | 3 | 0.000 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 1974 | 10 | 0.000 |
Why?
| | Hydroxylation | 1 | 1974 | 28 | 0.000 |
Why?
| | Microsomes, Liver | 1 | 1974 | 57 | 0.000 |
Why?
| | Mixed Function Oxygenases | 1 | 1974 | 37 | 0.000 |
Why?
| | Guinea Pigs | 1 | 1974 | 148 | 0.000 |
Why?
| | Aniline Compounds | 1 | 1974 | 73 | 0.000 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1974 | 108 | 0.000 |
Why?
| | Rabbits | 1 | 1975 | 755 | 0.000 |
Why?
| | Myocardial Contraction | 1 | 1975 | 316 | 0.000 |
Why?
| | Aged | 1 | 1992 | 19299 | 0.000 |
Why?
| | Guanine Nucleotides | 1 | 1972 | 16 | 0.000 |
Why?
| | Neoplasm Proteins | 1 | 1975 | 388 | 0.000 |
Why?
| | Animals, Newborn | 1 | 1974 | 779 | 0.000 |
Why?
| | Blood Platelets | 1 | 1975 | 350 | 0.000 |
Why?
| | Piperazines | 1 | 1974 | 313 | 0.000 |
Why?
| | Postpartum Period | 1 | 1974 | 281 | 0.000 |
Why?
| | Gestational Age | 1 | 1974 | 757 | 0.000 |
Why?
| | Amino Acids | 1 | 1975 | 455 | 0.000 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1975 | 1868 | 0.000 |
Why?
| | Fetus | 1 | 1974 | 703 | 0.000 |
Why?
| | Adenosine Triphosphate | 1 | 1972 | 430 | 0.000 |
Why?
| | RNA, Messenger | 1 | 1976 | 2581 | 0.000 |
Why?
| | Rats | 1 | 1975 | 5035 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1975 | 1486 | 0.000 |
Why?
| | Mice, Inbred C57BL | 1 | 1975 | 4767 | 0.000 |
Why?
| | Aging | 1 | 1974 | 1641 | 0.000 |
Why?
| | Pregnancy | 1 | 1974 | 5555 | 0.000 |
Why?
|
|
Boublik's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|